PD-L1 Immunotherapy shrinks tumors in Bladder Cancer Patients

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:2120 / 2120
页数:1
相关论文
共 50 条
  • [1] A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now
    Bellmunt, Joaquin
    Powles, Thomas
    Vogelzang, Nicholas J.
    CANCER TREATMENT REVIEWS, 2017, 54 : 58 - 67
  • [2] PD-1/PD-L1 and immunotherapy for pancreatic cancer
    Feng, Mengyu
    Xiong, Guangbing
    Cao, Zhe
    Yang, Gang
    Zheng, Suli
    Song, Xujun
    You, Lei
    Zheng, Lianfang
    Zhang, Taiping
    Zhao, Yupei
    CANCER LETTERS, 2017, 407 : 57 - 65
  • [3] Prognostic importance of PD-L1 expression in bladder cancer patients
    Durur, Sumeyye
    Uzun, Hakki
    Bedir, Recep
    Nalkiran, Ihsan
    Nalkiran, Hatice Sevim
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 2) : S633 - S638
  • [4] Prognostic importance of PD-L1 expression in bladder cancer patients
    Durur, Sumeyye
    Uzun, Hakki
    Bedir, Recep
    Nalkiran, Ihsan
    Nalkiran, Hatice Sevim
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 : S633 - S638
  • [5] Research progress of PD-1/PD-L1 immunotherapy in gastrointestinal tumors
    Sun, Jiangang
    Zheng, Yichao
    Mamun, M. A. A.
    Li, Xiaojing
    Chen, Xiaoping
    Gao, Yongshun
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 129
  • [6] PD-1/PD-L1 IMMUNOTHERAPY IS EFFECTIVE IN ADVANCED SOLID TUMORS
    不详
    CANCER DISCOVERY, 2012, 2 (07) : 581 - 581
  • [7] PD-L1 as a Biomarker in Gastric Cancer Immunotherapy
    Cho, Yunjoo
    Ahn, Soomin
    Kim, Kyoung-Mee
    JOURNAL OF GASTRIC CANCER, 2025, 25 (01) : 177 - 191
  • [8] Mitochondrial PD-L1 modulates cancer immunotherapy
    Dai, Xiaoming
    Liu, Jing
    Wei, Wenyi
    CELL RESEARCH, 2023, 33 (05) : 335 - 336
  • [9] PD-L1 peptides in cancer immunoimaging and immunotherapy
    Du, Shiye
    Liu, Junzhi
    Zhang, Youjia
    Ge, Xiaoguang
    Gao, Shi
    Song, Jibin
    JOURNAL OF CONTROLLED RELEASE, 2025, 378 : 1061 - 1079
  • [10] PD-L1 degradation pathway and immunotherapy for cancer
    Gou, Qian
    Dong, Chen
    Xu, Huihui
    Khan, Bibimaryam
    Jin, Jianhua
    Liu, Qian
    Shi, Juanjuan
    Hou, Yongzhong
    CELL DEATH & DISEASE, 2020, 11 (11)